Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers. Their stool tests utilize RNA profiles from intestinal cells to accurately diagnose IBD, assess inflammation severity and location, and predict therapy response. This method aims to replace invasive procedures like endoscopies with a convenient, home-based testing alternative, offering precise, cost-effective monitoring and disease management.